IBD: Safety and Positioning of IL-23 Inhibitors Under Investigation

Поділитися
Вставка
  • Опубліковано 19 лис 2024

КОМЕНТАРІ • 3

  • @athomas3386
    @athomas3386 10 місяців тому

    This is very informative.
    As a Plaque Psoriasis patient who had an Alopecia response (now resolved after discontinuing) to a first time use of a biologic Imraldi (Humira) I was looking for a non Anti TNF biologic and I will be pursuing the use of Stelara (ustekinumab)
    Possibly an IL 23 only biologic in the future
    Thank you

  • @michaelkurbah4325
    @michaelkurbah4325 2 роки тому

    we need a cure not your lecture

    • @JayInUrJungle
      @JayInUrJungle 2 роки тому

      How would they find a cure without learning from data on previous treatments?